Latest filing published 28 Aug 2026 for Clariane SE, €40k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
HLD Europe SCA is a declared insider at 2 companies; the most frequent names are Clariane SE and Exosens. In total, 53 filings cover trades dated from 13 June 2024 to 24 August 2026.
Both buying and selling appear: 33 purchases worth €156.7M, against 17 sales worth €561.3M. Sales outweigh purchases by €404.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 16 purchases and 3 sales on the market.
A typical purchase (the median) is worth €84k. Relative to company size, the median is 0.0050% of market cap (10 purchases with a known value). Clusters matter here: 8 out of 33 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 28 August 2026 came the latest disclosure, an open-market purchase for €40k in Clariane SE. Typically, a trade is published a median of 6 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 53 declarations